The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution

• 作 者: CHEN AiLi YANG JingYi HU ShaoYan WANG Qian-Fei
• 机 构: Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of
• 出 处: Science China(Life Sciences)
• 发表日期: 2015年12期
• 关键词: regimen chemotherapy interfere myeloid clonal dividing subgroup induction clone

Chemotherapy employs chemical substances to interfere with the growth of cancer cells,and is a major treatment strategy in human cancer including acute myeloid leukemia(AML).Although they often effectively kill fast-dividing tumor cells,chemotherapeutic drugs also profoundly affect

Chemotherapy employing chemical substances to interfere with the growth of cancer cells, and is a major treatment strategy in human cancer including acute myeloid leukemia (AML) .Although they often effectively kill fast-dividing tumor cells, chemotherapeutic drugs also profoundly affect